Norbrook Laboratories, Ltd. announces the introduction of Hexasol Injection, the only medication on the U.S. market that combines the long-acting antibiotic oxytetracycline (active ingredient in Noromycin™ 300 LA & 300 PRO LA™) and the non-steroidal anti-inflammatory drug (NSAID) flunixin meglumine in one convenient dose.
